Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • April 2012
  • Case
  • HBS Case Collection

Novozymes: Cracking the Emerging Markets Code

By: Krishna G. Palepu and Karol Misztal
  • Format:Print
  • | Language:English
  • | Pages:22
ShareBar

Abstract

In 2011, the management of Novozymes, the industrial enzymes leader, reflected on the viability of their positioning in the fast growing, yet increasingly competitive Chinese market. Novozymes, a technological innovation pioneer, was prominent in China's premium enzyme markets, but felt pressure from local low-cost rivals in volume-driven, commoditized segments. How should Novozymes relate to local competitors? By competing on technological innovation only in high-margin verticals? Or through a separate subsidiary with a new low-cost business model for commoditized verticals?

Citation

Palepu, Krishna G., and Karol Misztal. "Novozymes: Cracking the Emerging Markets Code." Harvard Business School Case 112-084, April 2012.
  • Educators
  • Purchase

About The Author

Krishna G. Palepu

Accounting and Management
→More Publications

Related Work

    • June 2013
    • Faculty Research

    Novozymes/Henrik Meyer, V.P. of Marketing and Business Development, Novozymes

    By: Krishna G. Palepu
Related Work
  • Novozymes/Henrik Meyer, V.P. of Marketing and Business Development, Novozymes By: Krishna G. Palepu
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.